Thermo Fisher Scientific Inc. (TMO)
NYSE: TMO · Real-Time Price · USD
694.76
+17.82 (2.63%)
At close: Nov 6, 2026, 4:00 PM EST
692.00
-2.76 (-0.40%)
After-hours: Nov 6, 2026, 7:41 PM EST

Thermo Fisher Financials Overview

Millions USD. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal Quarter
Q3 2026Q2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023Q3 2023Q2 2023Q1 2023Q4 2022Q3 2022Q2 2022Q1 2022Q4 2021
Period EndingSep '26 Jun '26 Mar '26 Dec '25 Sep '25 Jun '25 Mar '25 Dec '24 Sep '24 Jun '24 Mar '24 Dec '23 Sep '23 Jul '23 Apr '23 Dec '22 Oct '22 Jul '22 Apr '22 Dec '21
Revenue
12,13711,99411,00512,21511,12210,85510,36411,39510,59810,54110,34510,88610,57410,68710,71011,45010,67710,97011,81810,702
Revenue Growth
9.13%10.49%6.19%7.20%4.94%2.98%0.18%4.68%0.23%-1.37%-3.41%-4.93%-0.97%-2.58%-9.38%6.99%14.44%18.30%19.30%1.44%
Gross Profit
5,1404,9104,4445,0444,5934,4194,2464,8444,3374,3474,2204,4154,3304,2694,1814,6064,3024,5995,4645,246
Operating Income
2,4512,2491,9692,5862,1491,9471,8402,2621,9121,8331,7251,9911,9761,7851,7242,0361,7271,9822,8302,758
Net Income
1,7211,7361,6511,9641,6161,6171,5071,8301,6301,5481,3281,6301,7151,3611,2891,5761,4951,6642,2151,658
Earnings Per Share
4.644.684.435.194.274.283.984.784.254.043.464.204.423.513.323.993.794.225.614.16
EPS Growth
8.67%9.38%11.31%8.59%0.47%5.89%15.03%13.81%-3.85%15.10%4.22%5.38%16.62%-16.83%-40.82%-4.18%-20.88%-8.46%-4.59%-33.28%

Revenue by Segment

Fiscal Quarter
Q3 2026Q2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023Q3 2023Q2 2023Q1 2023Q4 2022Q3 2022Q2 2022Q1 2022Q4 2021
Period EndingSep '26 Jun '26 Mar '26 Dec '25 Sep '25 Jun '25 Mar '25 Dec '24 Sep '24 Jun '24 Mar '24 Dec '23 Sep '23 Jul '23 Apr '23 Dec '22 Oct '22 Jul '22 Apr '22 Dec '21
Life Sciences Solutions
2,7192,8152,6362,9462,5882,4992,3412,6042,3872,3552,2852,4692,4332,4632,6123,0462,9623,2924,2314,150
Analytical Instruments
2,0021,8471,7162,2151,8931,7281,7182,1861,8081,7821,6872,0371,7541,7491,7231,8781,6211,6071,5181,725
Specialty Diagnostics
1,0981,2051,1421,2201,1741,1341,1481,1571,1291,1171,1091,1051,0831,1091,1081,1151,0651,1011,4821,447
Laboratory Products and Biopharma Services
6,8636,6936,0366,3795,9705,9955,6405,9365,7405,7585,7235,7195,7285,8315,7635,9475,5855,5375,4424,195
Revenue (Total)
12,13711,99411,00512,21511,12210,85510,36411,39510,59810,54110,34510,88610,57410,68710,71011,45010,67710,97011,81810,702

Cash & Debt

Fiscal Quarter
Q3 2026Q2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023Q3 2023Q2 2023Q1 2023Q4 2022Q3 2022Q2 2022Q1 2022Q4 2021
Period EndingSep '26 Jun '26 Mar '26 Dec '25 Sep '25 Jun '25 Mar '25 Dec '24 Sep '24 Jun '24 Mar '24 Dec '23 Sep '23 Jul '23 Apr '23 Dec '22 Oct '22 Jul '22 Apr '22 Dec '21
Cash & Investments
6,0614,0643,25610,1053,5466,3905,9475,5706,6458,8237,2508,0806,1513,1333,4828,5242,9191,8882,7524,477
Total Debt
41,37042,54943,16140,85535,68035,22934,25932,77535,51335,42735,66436,71135,43634,02335,33636,15829,16030,26033,25536,339
Net Cash (Debt)
-35,309-38,485-39,905-30,750-32,134-28,839-28,312-27,205-28,868-26,604-28,414-28,631-29,285-30,890-31,854-27,634-26,241-28,372-30,503-31,862
Net Cash Growth
--------------------
Net Cash Per Share
-95.17-103.73-106.98-81.56-85.01-76.29-74.70-71.03-75.18-69.46-73.99-73.79-75.48-79.61-82.10-70.32-66.43-72.01-77.22-80.06

Cash Flow & CapEx

Fiscal Quarter
Q3 2026Q2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023Q3 2023Q2 2023Q1 2023Q4 2022Q3 2022Q2 2022Q1 2022Q4 2021
Period EndingSep '26 Jun '26 Mar '26 Dec '25 Sep '25 Jun '25 Mar '25 Dec '24 Sep '24 Jun '24 Mar '24 Dec '23 Sep '23 Jul '23 Apr '23 Dec '22 Oct '22 Jul '22 Apr '22 Dec '21
Operating Cash Flow
2,5502,1251,1923,4572,2391,3997233,2902,1661,9601,2513,7232,4141,5407293,4871,9371,5282,2022,457
Capital Expenditures
-437-450-376-465-404-294-362-480-272-301-347-405-332-284-458-550-547-506-640-831
Free Cash Flow
2,1131,6758162,9921,8351,1053612,8101,8941,6599043,3182,0821,2562712,9371,3901,0221,5621,626
Free Cash Flow Growth
15.15%51.58%126.04%6.48%-3.12%-33.39%-60.07%-15.31%-9.03%32.09%233.58%12.97%49.78%22.90%-82.65%80.63%-34.62%-39.42%15.70%-40.94%

Margins

Fiscal Quarter
Q3 2026Q2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023Q3 2023Q2 2023Q1 2023Q4 2022Q3 2022Q2 2022Q1 2022Q4 2021
Period EndingSep '26 Jun '26 Mar '26 Dec '25 Sep '25 Jun '25 Mar '25 Dec '24 Sep '24 Jun '24 Mar '24 Dec '23 Sep '23 Jul '23 Apr '23 Dec '22 Oct '22 Jul '22 Apr '22 Dec '21
Gross Margin
42.35%40.94%40.38%41.29%41.30%40.71%40.97%42.51%40.92%41.24%40.79%40.56%40.95%39.95%39.04%40.23%40.29%41.92%46.23%49.02%
Operating Margin
20.19%18.75%17.89%21.17%19.32%17.94%17.75%19.85%18.04%17.39%16.68%18.29%18.69%16.70%16.10%17.78%16.18%18.07%23.95%25.77%
Pretax Margin
17.13%15.91%15.68%17.38%16.44%15.76%15.50%17.32%16.31%15.96%15.59%15.97%16.53%13.23%12.49%15.26%14.32%17.01%21.33%17.40%
Profit Margin
14.18%14.47%15.00%16.08%14.53%14.90%14.54%16.06%15.38%14.69%12.84%14.97%16.22%12.73%12.04%13.76%14.00%15.17%18.74%15.49%
FCF Margin
17.41%13.96%7.41%24.49%16.50%10.18%3.48%24.66%17.87%15.74%8.74%30.48%19.69%11.75%2.53%25.65%13.02%9.32%13.22%15.19%

Dividends

Fiscal Quarter
Q3 2026Q2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023Q3 2023Q2 2023Q1 2023Q4 2022Q3 2022Q2 2022Q1 2022Q4 2021
Period EndingSep '26 Jun '26 Mar '26 Dec '25 Sep '25 Jun '25 Mar '25 Dec '24 Sep '24 Jun '24 Mar '24 Dec '23 Sep '23 Jul '23 Apr '23 Dec '22 Oct '22 Jul '22 Apr '22 Dec '21
Dividend Per Share
0.4700.4700.4700.4300.4300.4300.4300.3900.3900.3900.3900.3500.3500.3500.3500.3000.3000.3000.3000.260
Dividend Per Share Growth
9.30%9.30%9.30%10.26%10.26%10.26%10.26%11.43%11.43%11.43%11.43%16.67%16.67%16.67%16.67%15.38%15.38%15.38%15.38%18.18%
Dividend Yield
0.27%0.35%0.37%0.30%0.36%0.40%0.32%0.30%0.25%0.27%0.25%0.26%0.26%0.25%0.22%0.22%0.23%0.20%0.18%0.16%

Valuation

Fiscal Quarter
Q3 2026Q2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023Q3 2023Q2 2023Q1 2023Q4 2022Q3 2022Q2 2022Q1 2022Q4 2021
Period EndingSep '26 Jun '26 Mar '26 Dec '25 Sep '25 Jun '25 Mar '25 Dec '24 Sep '24 Jun '24 Mar '24 Dec '23 Sep '23 Jul '23 Apr '23 Dec '22 Oct '22 Jul '22 Apr '22 Dec '21
PE Ratio
35.2927.3725.6832.4726.6823.4128.9631.4138.2533.9336.7334.2133.3335.1836.8831.2228.2628.8530.4834.04
Forward PE
25.6920.2219.2224.0519.8117.9221.4122.8727.3124.8226.9324.6521.3921.2524.2725.0022.6625.0226.2932.55
P/FCF Ratio
32.8626.0526.0634.6028.6924.9828.0627.3830.1926.5129.3229.6130.2534.3839.5331.4035.4833.8733.1038.73
PS Ratio
5.274.123.894.894.013.574.404.645.544.995.224.794.564.625.074.834.505.015.646.71